Stephen P. Harrington
Präsident bei SPH Investments, Inc.
Aktive Positionen von Stephen P. Harrington
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SPH Investments, Inc. | Präsident | 01.01.1992 | - |
SPH Equities, Inc. | Präsident | 15.10.2010 | - |
Karriereverlauf von Stephen P. Harrington
Ehemalige bekannte Positionen von Stephen P. Harrington
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Zone Mining Ltd.
Zone Mining Ltd. Other Metals/MineralsNon-Energy Minerals Zone Mining Ltd. engaged in precious metals and jewels mining industry. The company was founded on January 31, 2005 and was headquartered in Bala Cynwyd, PA. | Vorsitzender | 01.01.2007 | 01.01.2007 |
Finanzdirektor/CFO | 01.01.2007 | 01.01.2007 | |
Präsident | - | 01.01.2007 | |
Unternehmenssekretär | 01.01.2007 | 01.01.2007 | |
Treasurer | 01.01.2007 | 01.01.2007 | |
Touchstone Resources USA, Inc. | Vorsitzender | 01.08.2005 | 01.08.2005 |
Präsident | - | 01.08.2005 | |
Unternehmenssekretär | 01.08.2005 | 01.08.2005 | |
Treasurer | 01.08.2005 | 01.08.2005 | |
ENDEAVOUR INTERNATIONAL CORPORATION | Vorstandsvorsitzender | 01.10.2001 | 01.02.2004 |
Vorsitzender | 01.10.2001 | 01.02.2004 | |
RADIANT LOGISTICS, INC. | Direktor/Vorstandsmitglied | 26.10.2007 | - |
Independent Dir/Board Member | 26.10.2007 | - | |
Astralis Ltd.
Astralis Ltd. BiotechnologyHealth Technology Astralis Ltd. research and develop drugs for the treatment of immune system disorders and skin diseases. The company's initial product is Psoraxine, a protein extract used for the treatment of the skin disease psoriasis. Psoraxine is a synthesized immuno-therapeutic agent, presented in liquid form and is packed in 0.5 mg ampules for intra-muscular injection. The company's second product is for the treatment of leishmaniasis. The company was founded on June 30, 2001 and is headquartered in Fairfield, NJ. | Direktor/Vorstandsmitglied | - | - |
iCarbon Corp.
iCarbon Corp. Other Metals/MineralsNon-Energy Minerals iCarbon Corp. mines and manufactures natural and synthetic graphite and carbon-based materials. The private company is based in Delano, PA and has subsidiaries in Canada, United States, and China. James E. Olive has been the CEO of the company since 2006. | Direktor/Vorstandsmitglied | - | - |
Ausbildung von Stephen P. Harrington
Yale University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 10 |
Operativ
President | 4 |
Chairman | 3 |
Director/Board Member | 3 |
Sektoral
Non-Energy Minerals | 3 |
Energy Minerals | 3 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
RADIANT LOGISTICS, INC. | Transportation |
Private Unternehmen | 7 |
---|---|
Zone Mining Ltd.
Zone Mining Ltd. Other Metals/MineralsNon-Energy Minerals Zone Mining Ltd. engaged in precious metals and jewels mining industry. The company was founded on January 31, 2005 and was headquartered in Bala Cynwyd, PA. | Non-Energy Minerals |
Touchstone Resources USA, Inc. | Energy Minerals |
Endeavour International Corp.
Endeavour International Corp. Oil & Gas ProductionEnergy Minerals Endeavour International Corp. was engaged in exploration and development of oil and gas reserves. The company was founded by William L. Transier and John N. Seitz and was headquartered in Houston, TX. | Energy Minerals |
SPH Investments, Inc. | |
SPH Equities, Inc. | |
iCarbon Corp.
iCarbon Corp. Other Metals/MineralsNon-Energy Minerals iCarbon Corp. mines and manufactures natural and synthetic graphite and carbon-based materials. The private company is based in Delano, PA and has subsidiaries in Canada, United States, and China. James E. Olive has been the CEO of the company since 2006. | Non-Energy Minerals |
Astralis Ltd.
Astralis Ltd. BiotechnologyHealth Technology Astralis Ltd. research and develop drugs for the treatment of immune system disorders and skin diseases. The company's initial product is Psoraxine, a protein extract used for the treatment of the skin disease psoriasis. Psoraxine is a synthesized immuno-therapeutic agent, presented in liquid form and is packed in 0.5 mg ampules for intra-muscular injection. The company's second product is for the treatment of leishmaniasis. The company was founded on June 30, 2001 and is headquartered in Fairfield, NJ. | Health Technology |
- Börse
- Insiders
- Stephen P. Harrington
- Erfahrung